About: Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.52 (+1.20%)
TARA NASDAQ Protara Therapeutics Inc
Protara Therapeutics Inc share price
Atividade de preço de TARA
Último preço
$ 2,520
Variação (24h)
0,03 USD (1,20%)
Volume
553.34K
Volume (média 4 sem.)
-
Abertura
$ 2,52
Variação do dia
$ 2,50 - $ 2,63
Fechamento anterior
$ 2,49
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
TARA price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals